Package 69097-125-15

{"route": ["ORAL"], "spl_id": "71f493d9-3aaa-4b13-8057-012e96e11dbc", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["ca4ec248-285d-4066-8f89-5ed0c538c4c9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (69097-125-03)", "package_ndc": "69097-125-03", "marketing_start_date": "20140612"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69097-125-12)", "package_ndc": "69097-125-12", "marketing_start_date": "20140612"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-125-15)", "package_ndc": "69097-125-15", "marketing_start_date": "20140612"}], "brand_name": "Topiramate", "product_id": "69097-125_71f493d9-3aaa-4b13-8057-012e96e11dbc", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69097-125", "generic_name": "Topiramate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}